EnGeneIC’s second generation COVID-19 vaccine protects against all variants
SYDNEY, Australia, June 28, 2022 (GLOBE NEWSWIRE) -- The world’s first COVID-19 vaccine to offer immunity against all variants is...
SYDNEY, Australia, June 28, 2022 (GLOBE NEWSWIRE) -- The world’s first COVID-19 vaccine to offer immunity against all variants is...
TORONTO, June 28, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical...
- 87% of patients who experienced ototoxicity in their placebo-treated ear were protected from ototoxicity in their DB-020-treated ear –...
First-in-class, oral, RAS(ON) Inhibitor being evaluated initially in patients with cancers driven by KRASG12 mutations Sushil Patel, Ph.D., industry veteran...
NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel...
LEIDEN, Netherlands & CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company...
RESEARCH TRIANGLE PARK, N.C., June 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company...
CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), an oncology company focused on developing next-generation...
Potential blockbuster VTAMA® (tapinarof) approved by FDA for the treatment of plaque psoriasis at end of May 2022 is the...
Dorval, Quebec--(Newsfile Corp. - June 28, 2022) - West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTC Pink: WIBFF) ("West...
● Red Light Holland launches: 'Red Light. Set. Go!' program to work with exceptional local Oregonians from diverse backgrounds who...
- Ohio State Wexner Medical Center and Siemens Healthineers have committed to a new strategic relationship to bring the most...
National Campaign to Feature Eye-Catching Experience in Four Major Metropolitan Cities Beginning June 27 KALAMAZOO, Mich.--(BUSINESS WIRE)--#rebuildinglivestogether--Stryker (NYSE:SYK), one of...
Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1; in all five placebo-controlled studies completed to date,...
PARIS, FRANCE / ACCESSWIRE / June 28, 2022 / Pharnext SA (FR0011191287 - ALPHA) (the "Company"), an advanced late-clinical stage...
VANCOUVER, BC / ACCESSWIRE / June 27, 2022 / Verisante Technology Inc. (NEX:VER.H) (the "Company") announces that further to the...
New study by Protiviti and ISACA underscores security risks looming large in today's dynamic threat landscape MENLO PARK, Calif., June...
Under Clearlake's ownership, Brightly transformed into a leading cloud-based asset management software platform with a broad suite of products solving...
ELMAU, Germany, June 27, 2022 /CNW/ - Canada is committed to standing in unity to support the government and people of...
Cloud Assurance Certified technologies must undergo the rigorous compliance, security, and data integrity assessment by USDM Life Sciences and demonstrate...